Ross Bray
Impact in
-
- Diabetes Treatment and Management
- Diabetes Management and Research
- Diet, Metabolism, and Disease
- Pharmacology top 2%
- Pharmacology and Obesity Treatment
Papers in ⓘ
-
- Diabetes Treatment and Management 12
- Diabetes Management and Research 5
- Diet, Metabolism, and Disease 2
- Co-authors
- Ángel Rodríguez (11 shared papers)Laura Fernández Landó (9 shared papers)Axel Haupt (6 shared papers)Deborah A. Robins (6 shared papers)Juan P. Frías (5 shared papers)Hiren Patel (3 shared papers)Dominik Dahl (1 shared paper)Yukiko Onishi (1 shared paper)
- Journals
- Diabetes (5 papers)Diabetes Obesity and Metabolism (3 papers)Therapeutic Innovation & Regulatory Science (2 papers)The Lancet Diabetes & Endocrinology (2 papers)The Journal of Clinical Endocrinology & Metabolism (1 paper)
- Partner nations
- United StatesGermanySpain
In The Last Decade
Ross Bray
21 papers receiving 1.9k citations
Hit Papers
Peers
Comparison fields: 5 of 74
- Endocrinology, Diabetes and Metabolism 1.5k
- Pharmacology 526
- Physiology 473
- Epidemiology 425
- Endocrine and Autonomic Systems 81
Countries citing papers authored by Ross Bray
This map shows the geographic impact of Ross Bray's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ross Bray with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ross Bray more than expected).
Fields of papers citing papers by Ross Bray
This network shows the impact of papers produced by Ross Bray. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ross Bray. The network helps show where Ross Bray may publish in the future.
Co-authors
The 25 scholars most cited alongside Ross Bray, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Once-weekly tirzepatide versus once-daily insulin degludec as add-on to metformin with or without SGLT2 inhibitors in patients with type 2 diabetes (SURPASS-3): a randomised, open-label, parallel-group, phase 3 trial Hit paper breakdown → | 2021 | 411 |
| 2 | Effect of Subcutaneous Tirzepatide vs Placebo Added to Titrated Insulin Glargine on Glycemic Control in Patients With Type 2 Diabetes Hit paper breakdown → | 2022 | 387 |
| 3 | Effect of tirzepatide versus insulin degludec on liver fat content and abdominal adipose tissue in people with type 2 diabetes (SURPASS-3 MRI): a substudy of the randomised, open-label, parallel-group, phase 3 SURPASS-3 trial Hit paper breakdown → | 2022 | 328 |
| 4 | Effects of Novel Dual GIP and GLP-1 Receptor Agonist Tirzepatide on Biomarkers of Nonalcoholic Steatohepatitis in Patients With Type 2 Diabetes Hit paper breakdown → | 2020 | 271 |
| 5 | 2020 | 220 | |
| 6 | 2020 | 171 | |
| 7 | Tirzepatide and muscle composition changes in people with type 2 diabetes (SURPASS-3 MRI): a post-hoc analysis of a randomised, open-label, parallel-group, phase 3 trial Hit paper breakdown → | 2025 | 23 |
| 8 | 2024 | 18 | |
| 9 | 2023 | 18 | |
| 10 | 2022 | 15 | |
| 11 | 2023 | 10 | |
| 12 | 2021 | 5 | |
| 13 | 2019 | 5 | |
| 14 | 2019 | 4 | |
| 15 | 2022 | 3 | |
| 16 | 2019 | 2 | |
| 17 | 2023 | 1 | |
| 18 | Statistics of Solar Seeing | 1966 | 1 |
| 19 | 2022 | 1 | |
| 20 | 2022 | 1 |
About Ross Bray
Ross Bray is a scholar working on Endocrinology, Diabetes and Metabolism, Family Practice, Pharmacology, Statistics and Probability and Physiology, having authored 21 papers that have together received 1.9k indexed citations. Recurring topics across this work include Diabetes Treatment and Management (12 papers), Metabolism, Diabetes, and Cancer (8 papers), Liver Disease Diagnosis and Treatment (6 papers), Diabetes Management and Research (5 papers), Pharmacology and Obesity Treatment (5 papers), Diet and metabolism studies (4 papers), Diet, Metabolism, and Disease (2 papers) and Health Systems, Economic Evaluations, Quality of Life (2 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (1.5k citations), Pharmacology (526 citations), Physiology (473 citations), Epidemiology (425 citations) and Endocrine and Autonomic Systems (81 citations). Ross Bray has collaborated with scholars based in United States, Germany and Spain. Frequent co-authors include Ángel Rodríguez, Laura Fernández Landó, Axel Haupt, Deborah A. Robins, Juan P. Frías, Hiren Patel, Dominik Dahl, Yukiko Onishi, Ruth Huh and Bram Brouwers. Their work appears in journals such as Diabetes, Diabetes Obesity and Metabolism, Therapeutic Innovation & Regulatory Science, The Lancet Diabetes & Endocrinology and The Journal of Clinical Endocrinology & Metabolism.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.